|
Madame
Chair,
Colleagues,
Welcome to the beautiful city of Florence and to
the fourth of the WHO Executive Board retreats.
On behalf of us all, I thank Dr Marta di Gennaro,
the authorities in Tuscany, and the Government of Italy for making
this important event possible. The contribution of the host nation is
essential to enable us to have these get-togethers.
Each of the last three retreats have given us an
opportunity to work together in ways that make us more effective in
executing our roles in governing the World Health Organization. I am
delighted that the Regional Directors have been able to join me for
this session, and that a number of the Executive Directors are coming
from Geneva.
The term "retreat" gives the notion of
people hiding away in quiet - even solitary - contemplation. Given the
urgency of the problems we face, and the ever-changing nature of our
membership, it really would not be a good idea for us to use this
precious time in that way.
This event is, first and foremost, a re-union,
bringing together a group who last met in May of this year. A great
deal has happened in the intervening months, and together, we shall
take stock of some key issues in international health.
This event is also an opportunity for engagement
- for Executive Board members to examine, and become involved in, a
number of issues that have critical importance to our Member States.
Most importantly, it is an opportunity for constructive
interaction - among Executive Board and senior secretariat staff..
We can expect to interact in ways that are focused, with clear
purpose. We are all committed to an effective response to the health
challenges which face our world. We all seek ways for WHO to make a
better contribution to people's health. And we will focus,
particularly, on the health and well-being of those who are poor.
Indeed, the next three days will be more like a workshop.
We will be comparing experiences and personal perspectives, and
looking hard at the ways in which WHO responds to them. Our challenge
is - how can we best make a difference?
Together, over the last three years, we have
defined the functions in which we have a comparative advantage -
- The setting of standards and guidance based on evidence;
-
Managing the knowledge that gives us this
evidence;
-
Backing for research to help develop
guidance and new products;
-
Support for alliances to take forward
global and country action;
-
Technical assistance with individual
Member States; and
-
Global advocacy around critical health
issues.
We have focused our efforts on the specific health
issues that concern most of our Member States. The broad directions
for this focus are contained within our corporate strategy and are
threaded into most of our work.
- We concentrate on an effective response to the issues that
particularly affect the well-being of the world's poorest people;
-
We are examining and helping all with an
interest to address, both long-standing and emerging risks to
people's health;
-
We are working with countries to see how
best we can help them to improve system performance;
-
We are attempting to strengthen global
action for health within the context of other international
development strategies;
We have sought to ensure that health issues receive
the highest priority by Governments and others with influence. Good
health is definitely central to a healthy and prosperous life;
There has been a change in the global attitude to
international health issues. I sense that the change will be sustained
despite the events of 11 September. During the last three years we
have seen human health become one of the central priorities for both
international and national action - as one of the essential keys to
unlock well-being and prosperity for millions. Put simply,
re-evaluations of evidence available over the years show that the
world has seriously under-invested in health and health equity. The
consequences have reached deeply into the social, economic, human and
environmental dimensions of people's livelihoods.
WHO is expected, by its Member States, to respond
to this new interest through health stewardship on a global scale. We
are helping to show the way forward, encouraging effective action and
monitoring results - all with a view to continuous improvements in
health outcomes. It is not easy. We work with Member States whose
governments are stable and secure, and those that are destabilised by
conflicts - sometimes over many years. We work with Member States
whose per person GNP figures differ by a factor of nearly 100.
But, whatever the setting, we call for strategic
and evidence-based investment in the promotion of health. We deploy
staff to obtain reliable and enlightened assessments of different
aspects of the health situation. We encourage the formation of work
through alliances - including public, private and NGO bodies -
bringing together a range of interested parties under one strategy and
plan of action. We measure progress and impact, reflecting the
realities of local settings.
The institutional context within which we work is
changing too. Plans for a new global funding mechanism are taking
shape, and WHO is involved in (but does not itself direct) several
well established new alliances - like GAVI, Roll Back Malaria, Making
Pregnancy Safer and Stop TB - for country level action, and for
research.
We know that blanket prescriptions to all nations
are unlikely to be useful. Advice has to be tailored to the specific
circumstances of each country. Nevertheless -
- We expect to maintain our overarching emphasis on support for
the scaling up of the collective efforts to confront the priority
health conditions that cause such high loss of life at this time.
-
We will do more to ensure that the whole
of WHO contributes fully to the effectiveness of all action for
health - whoever undertakes it - within the individual Member
States that we serve.
-
To this end, we want to be certain that
all of us within the secretariat use the resources available to us
- whatever their source - as efficiently and effectively as
possible, and
-
We are due to tune up our systems for
managing information, people, funds and interactions throughout
the organization with a view to continuous improvements in our
performance and contribution to World Health.
Colleagues,
I have discussed the shape and content of this
workshop with the Chair. We all know that it is not a formal EB
meeting - not an occasion for formal statements and decision-making.
But our work this week should better prepare us for making decisions
when the time comes - in January and May next year. We have kept the
number of issues on the programme down so that there is sufficient
space for proper dialogue.
We start, tomorrow, reviewing our perspectives and
experiences on improving access to medicines. Professor Sallam asked
that we do this, and this seems appropriate given the high level of
international attention to this important issue, and as countries are
meeting in Doha. We will have the opportunity to work on this in small
groups.
Another area of interest to Executive Board members
is the interaction between public and private sectors in health
action. It happens everywhere, and Executive Board members may wish to
express views on their experiences in this area, and their
perspectives on how WHO should be responding to public-private
interactions.
At the last meeting of the Executive Board we
agreed that we would bring ourselves up-to-date on the Global AIDS and
Health Fund (now renamed as the Global Fund to fight AIDS, TB and
Malaria). So we have made space to discuss the Fund. I have also been
asked to describe progress on our work on health systems performance
assessment - a matter that led to extensive discussion both at the
Weggis retreat last year, and at the first EB meeting this year.
We are continuing to intensify the secretariat's
work on ethics and health: I have announced that we will establish a
new initiative to bring together existing work and intensify its
contribution. I value the opportunity to receive your comments on
this.
Thank you.
|